NCT04284774 2025-12-04Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment TrialNational Cancer Institute (NCI)Phase 2 Active not recruiting5 enrolled 9 charts
NCT05605522 2025-08-24A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours3B Pharmaceuticals GmbHPhase 1 Terminated19 enrolled